Cystatin C as a risk factor for outcomes in chronic kidney disease - Wikidata - wikimedia - TriplyDB

Cystatin C as a risk factor for outcomes in chronic kidney disease

Cystatin C as a risk factor for outcomes in chronic kidney disease

http://www.wikidata.org/entity/Q28235104

about

Inflammation and coagulation markers and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA)Comparison of CKD-EPI Cystatin C and Creatinine Glomerular Filtration Rate Estimation Equations in Asian Indians.Lack of Association between Serum Cystatin C Levels and Coronary Artery Disease in Diabetic Patients.Association of cystatin C with adverse outcomes.Urinary cystatin C is diagnostic of acute kidney injury and sepsis, and predicts mortality in the intensive care unit.Estimated glomerular filtration rate as an independent predictor of atherosclerotic vascular disease in older women.Higher levels of cystatin C are associated with worse cognitive function in older adults with chronic kidney disease: the chronic renal insufficiency cohort cognitive study.Klotho deficiency causes vascular calcification in chronic kidney disease.Decreased GFR estimated by MDRD or Cockcroft-Gault equation predicts incident CVD: the strong heart study.Metabolic syndrome and renal injury Estimated GFR associates with cardiovascular risk factors independently of measured GFR.Higher cystatin C level predicts long-term mortality in patients with peripheral arterial disease.Cystatin C, mortality risk and clinical triage in US adults: threshold values and hierarchical importance.Measured GFR does not outperform estimated GFR in predicting CKD-related complications Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study.Serum cystatin C - marker of inflammation and cardiovascular morbidity in chronic kidney disease stages 1-4 Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD.Filtration markers may have prognostic value independent of glomerular filtration rate Change in novel filtration markers and risk of ESRD.Estimating glomerular filtration rate in kidney transplantation: Still searching for the best marker Serum Cystatin C as an Indicator of Renal Function and Mortality in Liver Transplant Recipients Assessment and diagnosis of renal dysfunction in the ICU.Relationship between Estimated Glomerular Filtration Rate and Cardiovascular Mortality in a Japanese Cohort with Long-Term Follow-Up eGFR: is it ready for early identification of CKD?Cystatin C in a composite risk score for mortality in patients with infective endocarditis: a cohort study.Racial Disparities in Creatinine-based Kidney Function Estimates Among HIV-infected Adults.Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated with chronic kidney disease.Cystatin C--a paradigm of evidence based laboratory medicine.The natural history of, and risk factors for, progressive chronic kidney disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocol Association of visceral and subcutaneous adiposity with kidney function Change in Measured GFR Versus eGFR and CKD Outcomes.Cystatin C Predicts Incident Cardiovascular Disease in Twins.Update on cystatin C: incorporation into clinical practice.Cystatin C associates with arterial stiffness in older adults.Clinical correlates and heritability of cystatin C (from the Framingham Offspring Study)Estimated kidney function based on serum cystatin C and risk of subsequent coronary artery calcium in young and middle-aged adults with preserved kidney function: results from the CARDIA study Short-term changes after a weight reduction intervention in advanced diabetic nephropathy.Kidney function estimated from serum creatinine and cystatin C and peripheral arterial disease in NHANES 1999-2002.Cystatin C levels in functionally anephric patients undergoing dialysis: the effect of different methods and intensities.Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population.

P2860

Q28387350-397D6F00-1213-47D2-A420-A4171961AA63 Q33608612-DAB6B444-84C5-4C4C-BC9D-A6A8EE63C226 Q33904523-FC10267B-306D-4F2C-BAC2-B0F9F7DF8FB7 Q33932292-3E1985DE-103D-4A98-98BE-3E1E29102D78 Q34026824-07AFF48B-0C19-42B4-B7D3-C28D3901922E Q34338563-99CEC24F-F7F6-43A5-8C00-AB1509F15F59 Q34361219-B38527DD-78F4-40E7-A909-8B532BC9E241 Q34457281-94F0D806-3C4B-4223-BE33-44147486DC21 Q34519960-0B844174-08F2-4AFC-A376-6051FCE938E4 Q34725449-DA2EADCC-810B-4453-AA86-3CD5A8B7DF9A Q34870809-3675896D-BB92-422D-9827-EABD9A2F8180 Q35032801-FFAE6649-AAD7-45DE-B01C-F44E39B79618 Q35133144-EE4826F7-B7DD-4461-9F85-46DF50EAAF70 Q35272304-728637F5-7F37-4DF7-A948-12B0481694B8 Q35479461-2C7B0428-517B-4C28-BB21-886509CAAC34 Q35508233-2669AFA1-7E8A-440E-83FE-1C976AE6149B Q35566332-AFCDC04F-F2A4-4AEF-AD42-20F9FFB6443C Q35715869-920D17A8-D4F3-444F-A7FB-A3B3CAB3CEE1 Q35772896-C2275FB6-5A5A-4863-B1F7-CCF16DF3C786 Q35819414-BD77CF2C-BABC-4830-BD93-0AC3FBFDA09E Q36001110-3F188A23-B119-4B80-B499-D1A4AE42CF19 Q36009080-49CD4BA3-07EC-4BB9-B6DE-298DB69EBFC5 Q36043978-5B0EFC90-B141-4C66-9D23-082CE99858EF Q36063322-E55078D9-2B70-419E-9280-852EC70BFDBA Q36103793-F12E1744-EE6F-4EF5-BE17-1D30A49888CA Q36813322-210CF14B-2CA1-46F9-865B-521624437611 Q36867914-EB7188FF-3C41-4B2C-919D-1179A5A3804E Q36869663-CFF53B96-E645-4725-92A4-1C967E27A71B Q36875566-D3D993D9-F036-467A-B83F-10DD4D80E844 Q36947333-342FE2A9-FB03-43EF-A6BB-0F5E23557074 Q37051996-9B3BD2D7-22AE-4B5C-8BB5-E4466FCC4D84 Q37076093-35E4DA36-F50F-481A-BB9E-0A59F26C6BE3 Q37126287-9B090572-9368-43B3-BDC2-0606EECAE703 Q37181967-6A4EC549-4CE9-44FC-8F20-DB023AFB2754 Q37259589-36FD1112-2106-453B-9F56-D1BF158685C2 Q37276263-CAADCA39-45F6-4C35-95F7-2FDBCD88C6E1 Q37280851-81F9AB45-7B30-4B33-A0F1-A3A25A318C9A Q37285963-9EC76B1E-B8A8-4B33-AAD2-9B940142B035 Q37378450-6D2512E5-F2AF-4EC1-9147-899258FE527B Q37432938-4856C8A2-FAC9-4D89-9F37-E24687E9E08E

P2860

Cystatin C as a risk factor for outcomes in chronic kidney disease

http://www.wikidata.org/entity/Q28235104

description

2007 nî lūn-bûn

@nan

2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Cystatin C as a risk factor for outcomes in chronic kidney disease

@ast

Cystatin C as a risk factor for outcomes in chronic kidney disease

@en

Cystatin C as a risk factor for outcomes in chronic kidney disease

@nl

type

label

Cystatin C as a risk factor for outcomes in chronic kidney disease

@ast

Cystatin C as a risk factor for outcomes in chronic kidney disease

@en

Cystatin C as a risk factor for outcomes in chronic kidney disease

@nl

prefLabel

Cystatin C as a risk factor for outcomes in chronic kidney disease

@ast

Cystatin C as a risk factor for outcomes in chronic kidney disease

@en

Cystatin C as a risk factor for outcomes in chronic kidney disease

@nl

P1433

Q28235104-1920C723-1D92-4F6D-8491-B67156A0DA2C

P1476

Q28235104-FF9700F5-8BD6-461A-A7B4-72B57FCE6C21

P2093

Q28235104-1DB49C9E-AE39-45D6-A97A-FE04E15EB809

Q28235104-21B22484-3951-4E93-9447-BDCF69022303

Q28235104-3D7C13A1-9C15-4BEF-972E-0FF5ED6EE8D2

Q28235104-4B8C8539-85DE-48B9-99A8-31DD984D3BB8

Q28235104-6315091F-0197-4DB8-8360-AF5DB1D40B4C

Q28235104-63A82962-4DF0-4D1B-BC48-1D4C2F95AB67

Q28235104-760F07D6-F1F5-4D09-BD18-4CAC69000526

Q28235104-D483F674-1AB7-41D0-8454-ED376DD5AFC2

Q28235104-DB4D755E-FF29-402D-B872-FEA7A4F0A3F6

P304

Q28235104-8DF52094-218E-44C4-A6B6-BD24973426C9

P31

Q28235104-B8A68763-CB44-4505-BECB-309DDCD9E1D5

P3181

Q28235104-2C675A68-A132-48AE-B86E-1C343791CB6D

P356

Q28235104-8C9B81DB-2017-4EE0-B715-E9F56DDA0553

P407

Q28235104-2722E41E-BF85-420F-9650-4B9A9CE64FBB

P433

Q28235104-003826A3-3918-41E1-A8C2-1121BBF14821

P478

Q28235104-3349BCA1-0046-4CA5-BDA1-4F15214858C0

P50

Q28235104-1BACF417-7EC0-42C7-912E-D665B56434B4

Q28235104-6D2FD8E9-859E-4E02-A312-D9874C4EB0F7

P577

Q28235104-9F89C91F-FFF6-4C61-A1F7-6D94241AD804

P698

Q28235104-2FB44F6A-EBAD-4D34-9C13-7B06F7A4F20E

P921

Q28235104-55886CC2-09B5-453B-BAF1-260486F7009B

P3181

P356

0003-4819-147-1-200707030-00004

P1433

Annals of Internal Medicine

P1476

Cystatin C as a risk factor for outcomes in chronic kidney disease

@en

P2093

Allan J Collins

http://www.w3.org/2001/XMLSchema#string

Andrew S Levey

http://www.w3.org/2001/XMLSchema#string

Gerald J Beck

http://www.w3.org/2001/XMLSchema#string

John W Kusek

http://www.w3.org/2001/XMLSchema#string

Lesley Stevens

http://www.w3.org/2001/XMLSchema#string

Mark J Sarnak

http://www.w3.org/2001/XMLSchema#string

Tom Greene

http://www.w3.org/2001/XMLSchema#string

Vandana Menon

http://www.w3.org/2001/XMLSchema#string

Xuelei Wang

http://www.w3.org/2001/XMLSchema#string

P304

19-27

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1017504

http://www.w3.org/2001/XMLSchema#string

P356

10.7326/0003-4819-147-1-200707030-00004

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

147

http://www.w3.org/2001/XMLSchema#string

P50

Michael G Shlipak

P577

2007-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17606957

http://www.w3.org/2001/XMLSchema#string

P921